In summary, our study identifies ADAM17 as a physiological protease for TREM2 in microglia, establishes iRhom2 as a modifier of TREM2 shedding, and, thus, elucidates a mechanism by which iRhom2 may contribute to the biology underlying AD. This evidence concerns the gene ADAM17 and Alzheimer disease.